Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healthy volunteers needed to build digital health baseline

NCT ID NCT06679608

Knowledge-focused Sponsor: SYSNAV Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 129 healthy adults aged 18–65 over two years using a wearable device called Syde®. Participants are assessed every six months to measure walking speed and other movement patterns. The goal is to create a reference dataset of healthy movement, which can help develop and validate digital tools for detecting disease. No treatment is given; this is purely an observational study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

129 people

The number who actually took part.

Started

Jan 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects will be initially provided with information on the study through Ethics Committee validated advertising supports (paper and electronic posters and flyers). These supports will be displayed and distributed by the investigational sites.

Ages

18 to 65 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female aged between 18 and 65 years old * Signed informed consent * Subjects with a reported BMI ≥ 17 and ≤ 35 * Subject with unlimited internet connection at home and authorizing automatic data upload * Subject willing and able to comply with all study procedures including: * baseline data and questionnaires data entry on EDC (electronic data capture) throughout the study * Syde® related procedures * Subject confirming to be affiliated to, or beneficiary from, a social security category Exclusion Criteria: * Elite athletes (at a national level) * Pregnant women * Presence of an orthopedic, neuromuscular, or neurological pathology affecting walking gait quality or requiring a walking aid * Subjects reporting to have an incapacity or invalidity or to be affected by a chronic disease which can affect their activity and/or their lower limb function * Subjects reporting to have undergone recent surgical procedures, trauma (within 6 months), or affected by a disease or condition affecting lower limb function within 3 weeks before their inclusion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy adults

Contacts and locations

Locations

  • CHU ROUEN - Hôpital Charles Nicolle

    Rouen, 76000, France

  • Hospices Civils de Lyon - Hôpital Femme Mère Enfant (HFME)

    Bron, 69500, France

  • Hôpital NOVO (Nord-Ouest Val d'Oise)

    Pontoise, 95300, France

  • SYSNAV

    Vernon, 27200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.